Organovo CEO Murphy steps away, Crouch steps up | Personnel Moves – April 14, 2017

Organovo (PINK:ONVO) said earlier this week that Taylor Crouch has been appointed as CEO, replacing Keith Murphy who is stepping away from the company. The changes are slated to go into effect on April 21. Prior to being tapped for  the corner office, Crouch operated as CEO of investigative clinical research company eStudySite, the San Diego, Calif.-based company said. “I am extremely proud of the progress we have made in the last ten years achieving our vision for Organovo.  Our 3D bioprinted human tissues are a disruptive and game-changing technology.  Founding Organovo and guiding us to our leadership position in 3D bioprinting has been a privilege, and I am extremely grateful to my Organovo colleagues who assisted in building this success, as well as all of our partners and customers. I am a true believer in our existing tissue research services, the potential of our therapeutic liver tissue, and the future opportunities enabled by our platform technology.  The time is right to bring in a CEO with the relevant commercial experience to lead the company into its next stage.  I have great confidence in Organovo’s continued growth and success, and I look forward to working with the board and Taylor over the coming months to ensure that this transition is seamless for all of our stakeholders,” Murphy said in a prepared statement. Murphy is leaving “to pursue entrepreneurial opportunities,” according to the company, but will remain board chair an...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Active Implants AdvaMed Alphatec Holdings Inc. Anika Therapeutics Inc. Apollo Endosurgery Aurora Spine Baxter Biocorp Biogen Idec Biolase Technology Inc Bioventus LLC Bonesupport Clal Biotech Delcath Sys Source Type: news